• Non ci sono risultati.

(1)Recent Results in Cancer Research 166 Managing Editors P.M

N/A
N/A
Protected

Academic year: 2022

Condividi "(1)Recent Results in Cancer Research 166 Managing Editors P.M"

Copied!
5
0
0

Testo completo

(1)

Recent Results

in Cancer Research 166

Managing Editors

P.M. Schlag, Berlin H.-J. Senn, St. Gallen

Associate Editors

P. Kleihues, Lyon F. Stiefel, Lausanne B. Groner, Frankfurt  A. Wallgren, Gteborg

Founding Editors

P. Rentchnik, Geneva

(2)

H.-J. Senn · R. Morant (Eds.)

Tumor Prevention and Genetics III

With 29 Figures and 44 Tables

(3)

Professor Dr. Hans-Jrg Senn Dr. Rudolf Morant

Zentrum fr Tumordiagnostik und Prvention Rorschacherstrasse 150

9006 St. Gallen, Switzerland

Indexed in Current Contents and Index Medicus ISSN 0080-0015

ISBN 3-540-22228-6 Springer Berlin Heidelberg New York

Library of Congress Control Number: 2004110715

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provision of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the German Copyright Law.

Springer is a part of Springer Science+Business Media springeronline.com

 Springer-Verlag Berlin Heidelberg 2005 Printed in Germany

The use of designations, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant pro- tective laws and regulations and therefore free for general use.

Product liability: The publisher can not guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

Editor: Dr. Ute Heilmann, Heidelberg, Germany

Desk editor: Drthe Mennecke-Bhler, Heidelberg, Germany Production editor: Ingrid Haas, Heidelberg, Germany Typesetting: Strtz GmbH, Wrzburg, Germany Printing: Krips, Meppel, The Netherlands

Binding: Litges & Dopf GmbH, Heppenheim, Germany

Cover-design: design & production GmbH, Heidelberg, Germany Cover printing: Stolinski GmbH, Malsch, Germany

Printed on acid-free paper 21/3150/ih – 5 4 3 2 1 0

(4)

Contents

Lifestyle and Medical Approaches to Cancer Prevention . . . . 1 Peter Greenwald

Application of Genetics to the Prevention of Colorectal Cancer . . . . 17 John L. Hopper

Genetics and Prevention of Oesophageal Adenocarcinoma . . . . 35 Rebecca C. Fitzgerald

Preclinical Models Relevant to Diet, Exercise, and Cancer Risk . . . . 47 R. James Barnard, William J. Aronson

Individualizing Interventions for Cancer Prevention . . . . 63 Michael Pollak

Can Animal Models Help Us Select Specific Compounds

for Cancer Prevention Trials? . . . . 71 Ernest T. Hawk, Asad Umar, Ronald A. Lubet,

Levy Kopelovich, Jaye L. Viner

Problems with Using Biomarkers as Surrogate End Points for Cancer:

A Cautionary Tale . . . . 89 Arthur Schatzkin

Can a Marker Be a Surrogate for Development of Cancer,

and Would We Know It if It Exists? . . . . 99 William B. Armstrong, Thomas H. Taylor,

Frank L. Meyskens

How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner? . . . . 113

Frank Louis Meyskens, Eva Szabo

(5)

VI Contents The Problems with Risk Selection; Scientific and Psychosocial Aspects . . . 125

Anne-Rene Hartman

Chemoprevention of Lung Cancer . . . . 145 Stphane Vignot, Jean-Philippe Spano, Sylvie Lantuejoul, Fabrice Andr, Thierry Le Chevalier, Jean-Charles Soria

Anti-nicotine Vaccination: Where Are We? . . . . 167 T. Cerny

Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise . . . . 177 Mara Elena Martnez

Chemoprevention of Colorectal Cancer: Ready for Routine Use? . . . . 213 Nadir Arber, Bernard Levin

Screening of Colorectal Cancer: Progress and Problems . . . . 231 Sidney J. Winawer

The Role of Endogenous Hormones in the Etiology and Prevention

of Breast Cancer: The Epidemiological Evidence . . . . 245 Paola Muti

Innovative Agents in Cancer Prevention . . . . 257 Margaret M. Manson, Peter B. Farmer, Andreas Gescher,

William P. Steward

The IARC Commitment to Cancer Prevention:

The Example of Papillomavirus and Cervical Cancer . . . . 277 Silvia Franceschi

Health Economics in the Genomic Age . . . . 299 Thomas D. Szucs

Screening for Cancer: Are Resources Being Used Wisely? . . . . 315 Robert M. Kaplan

Riferimenti

Documenti correlati

Wenn jedoch neben der Sprache auch Symbole (hier im Sinne von unterschiedlichsten Gegenständen) ausgewählt werden, können Beratende mit dieser zusätzlichen Ebene

The European Commission support for the production of this publication does not constitute an endorsement of the contents which reflects the views only of the authors,

Lorenz chooses the euphemism of “different” to describe the quality of German clinical research, and notes that only two of 32 German fifth-year medical students could

Motivated by the possible association of some ultra-high energy (UHE) cosmic ray (CR) events with Cen A, we further analyze the acceleration efficiency for a number of a

EPK-EM The agencies involved in the case of breaches are the HZD, the GÜL, the probation worker, the police and either the sentencing court or the investigating judge (the latter

Desk editor: Dörthe Mennecke-Bühler, Heidelberg, Germany Production: PRO EDIT GmbH, Heidelberg, Germany Cover-Design: Frido Steinen-Broo, eStudio Calamar, Spain

A su- periority compared to the postoperative radiochemotherapy, still recommended by the consensus guidelines of the National Institutes of Health and the German Cancer Society,

The second time period comprises 332 patients with rectal tumours (including adenomas) having undergone endosonography by six different examiners after introduction of this